Loading...

Free Cash Flow Build Up

Aptevo Therapeutics Inc.

Aptevo Therapeutics Inc. (APVO)

Healthcare

Year
A/P
2014
Actual
2015
Actual
2016
Actual
2017
Actual
2018
Actual
2019
Projected
2020
Projected
2021
Projected
2022
Projected
2023
Projected
Revenue 45.6333.6036.4414.6623.0721.9020.7819.7318.7317.77
EBITDA -49.69-58.43-123.58-50.82-49.27-51.77-49.14-46.65-44.28-42.03
EBIT -51.71-61.34-126.94-53.95-51.66-54.14-51.39-48.78-46.30-43.95
Tax Rate 1.16%3.29%12.01%142.71%0.00%31.83%31.83%31.83%31.83%31.83%
EBIAT -51.11-59.32-111.7023.04-51.66-36.90-35.03-33.25-31.56-29.96
Depreciation 2.022.913.363.132.392.362.242.132.021.92
Accounts Receivable -7.372.172.14-3.080.910.220.210.200.19
Inventories --2.7013.685.61-0.76-4.000.290.280.260.25
Accounts Payable --1.391.40-4.144.32-3.47-0.42-0.40-0.38-0.36
Capital Expenditure -0.54-4.041.110.430.360.030.030.030.03
UFCF -49.09-52.59-95.1230.89-48.36-40.74-32.66-31.00-29.42-27.93
WACC
PV UFCF -40.74-32.66-31.00-29.42-27.93
SUM PV UFCF -